Chapter 3 80 non-binary gender identity (i.e. a gender identity outside of the binary gender identity options) and for 13.6% gender identity was missing. Data from MINI+ assessments indicate that at clinical intake, 47.2% of the participants had a lifetime diagnosis of depression or dysthymia. Depressive symptom severity at baseline and after GAHT At the start of GAHT, 22.4% of participants (n = 19) exhibited moderate, severe, or very severe depressive symptoms based on IDS-SR scores. In the TM group, 26% of participants (n=14) reported depressive symptoms of this severity and in the TF group, 16.1% of participants (n=5) reported symptoms of this severity. Following 12 months of GAHT, 16.5% of participants (n=14) still had moderate, severe, or very severe depression. 26% of TM participants (n=14) and 2.3% of TF participants (n=5) displayed depressive symptoms of this severity after 12 months of GAHT. Figure 3.2 shows a breakdown of IDS-SR categories for each group and time point. Figure 3.2. Depression severity based on IDS-SR scores at baseline and after 12 months of GAHT. Prevalences are displayed per group at the start of GAHT and after 12 months of GAHT. Only participants with complete IDS-SR questionnaires at baseline and 12 months were included in the figure. 3.2. Depression profile at the start of GAHT EFA analysis Analysis of baseline IDS-SR scores showed that the internal consistency of the IDS-SR in the total sample was good (Cronbach’s alpha=0.89). Results of the EFA analyses on the baseline measurements indicated that the 5-factor
RkJQdWJsaXNoZXIy MTk4NDMw